STOCK TITAN

Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC)

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Ginkgo Bioworks (NYSE: DNA) announced that its Ginkgo Automation division will design and deploy a flexible laboratory automation system for the Great Lakes Bioenergy Research Center (GLBRC) at the University of Wisconsin–Madison. The system aims to support biofuels and bioproducts research from plant biomass.

The new anaerobic-capable automation system will enable GLBRC scientists to run multiple experiments simultaneously across both aerotolerant and anaerobic conditions, increasing efficiency and 'walkaway' time. The system includes access to Catalyst Flow, a remote error resolution service expected to resolve 80-90% of system errors without user intervention.

Built on expertise from Ginkgo Bioworks and Zymergen, the customizable system focuses on automating workflows for anaerobic organisms, a key requirement for GLBRC's research programs. The technology aims to help GLBRC advance its mission of enabling cost-effective, sustainable biofuel production at scale.

Ginkgo Bioworks (NYSE: DNA) ha annunciato che la sua divisione Ginkgo Automation progetterà e installerà un sistema flessibile di automazione per laboratori presso il Great Lakes Bioenergy Research Center (GLBRC) dell'Università del Wisconsin-Madison. Questo sistema mira a supportare la ricerca sui biocombustibili e sui bioprodotti a partire dalla biomassa vegetale.

Il nuovo sistema di automazione, capace di operare in condizioni anaerobiche, consentirà agli scienziati del GLBRC di condurre più esperimenti simultaneamente sia in condizioni aerotoleranti che anaerobiche, aumentando l'efficienza e il tempo di 'walkaway'. Il sistema include l'accesso a Catalyst Flow, un servizio di risoluzione remota degli errori che si prevede risolverà l'80-90% degli errori del sistema senza intervento dell'utente.

Basato sull'expertise di Ginkgo Bioworks e Zymergen, il sistema personalizzabile si concentra sull'automazione dei flussi di lavoro per organismi anaerobici, un requisito fondamentale per i programmi di ricerca del GLBRC. La tecnologia mira ad aiutare il GLBRC a portare avanti la sua missione di abilitare una produzione sostenibile e economicamente conveniente di biocombustibili su larga scala.

Ginkgo Bioworks (NYSE: DNA) anunció que su división Ginkgo Automation diseñará e implementará un sistema de automatización de laboratorios flexible para el Great Lakes Bioenergy Research Center (GLBRC) en la Universidad de Wisconsin-Madison. Este sistema tiene como objetivo apoyar la investigación sobre biocombustibles y bioproductos a partir de biomasa vegetal.

El nuevo sistema de automatización, que puede funcionar en condiciones anaeróbicas, permitirá a los científicos de GLBRC realizar múltiples experimentos simultáneamente en condiciones aerotolerantes y anaeróbicas, aumentando la eficiencia y el tiempo de 'walkaway'. El sistema incluye acceso a Catalyst Flow, un servicio de resolución remota de errores que se espera resuelva entre el 80 y el 90% de los errores del sistema sin la intervención del usuario.

Basado en la experiencia de Ginkgo Bioworks y Zymergen, el sistema personalizable se centra en automatizar flujos de trabajo para organismos anaeróbicos, un requisito clave para los programas de investigación del GLBRC. La tecnología tiene como objetivo ayudar al GLBRC a avanzar en su misión de permitir la producción sostenible y rentable de biocombustibles a gran escala.

징코 바이오웍스 (NYSE: DNA)는 징코 오토메이션 부서가 위스콘신 대학교 매디슨 캠퍼스에 있는 그레이트 레이크 바이오에너지 연구 센터(GLBRC)를 위한 유연한 실험실 자동화 시스템을 설계하고 배포할 것이라고 발표했습니다. 이 시스템은 식물 바이오매스에서 나온 바이오 연료 및 바이오 제품 연구를 지원하는 것을 목표로 합니다.

새로운 혐기성 자동화 시스템은 GLBRC 과학자들이 공기 내성 및 혐기성 조건에서 동시에 여러 실험을 수행할 수 있게 하여 효율성과 '워크어웨이' 시간을 증가시킵니다. 이 시스템에는 사용자의 개입 없이 80-90%의 시스템 오류를 해결할 것으로 예상되는 원격 오류 해결 서비스인 Catalyst Flow에 대한 접근이 포함되어 있습니다.

징코 바이오웍스와 Zymergen의 전문 지식을 바탕으로 한 맞춤형 시스템은 GLBRC의 연구 프로그램에 대한 주요 요구 사항인 혐기성 유기체의 작업 흐름 자동화에 중점을 둡니다. 이 기술은 GLBRC가 비용 효율적이고 지속 가능한 바이오 연료 생산을 대규모로 진행할 수 있도록 도와주는 것을 목표로 합니다.

Ginkgo Bioworks (NYSE: DNA) a annoncé que sa division Ginkgo Automation concevra et déploiera un système d'automatisation de laboratoire flexible pour le Great Lakes Bioenergy Research Center (GLBRC) à l'Université du Wisconsin-Madison. Ce système vise à soutenir la recherche sur les biocarburants et les bioproduits à partir de biomasse végétale.

Le nouveau système d'automatisation, capable de fonctionner dans des conditions anaérobies, permettra aux scientifiques du GLBRC de mener plusieurs expériences simultanément dans des conditions aéro-tolérantes et anaérobies, augmentant ainsi l'efficacité et le temps de 'walkaway'. Le système inclut l'accès à Catalyst Flow, un service de résolution d'erreurs à distance qui devrait résoudre 80 à 90 % des erreurs système sans intervention de l'utilisateur.

Construit sur l'expertise de Ginkgo Bioworks et Zymergen, le système personnalisable se concentre sur l'automatisation des flux de travail pour les organismes anaérobies, un besoin clé pour les programmes de recherche du GLBRC. La technologie vise à aider le GLBRC à progresser dans sa mission de permettre une production de biocarburants durable et économiques à grande échelle.

Ginkgo Bioworks (NYSE: DNA) gab bekannt, dass seine Ginkgo Automation-Abteilung ein flexibles Automatisierungssystem für Labore für das Great Lakes Bioenergy Research Center (GLBRC) an der Universität Wisconsin-Madison entwerfen und implementieren wird. Das System soll die Forschung zu Biokraftstoffen und Bioprodukten aus pflanzlicher Biomasse unterstützen.

Das neue Automatisierungssystem, das anaerobe Fähigkeiten bietet, ermöglicht es den Wissenschaftlern des GLBRC, mehrere Experimente gleichzeitig sowohl unter aerotoleranten als auch anaeroben Bedingungen durchzuführen, was die Effizienz und die 'Walkaway'-Zeit erhöht. Das System beinhaltet den Zugang zu Catalyst Flow, einem Fernfehlerbehebungsdienst, dessen Erfolgsaussichten 80-90% der Systemfehler ohne Benutzerintervention beheben können.

Das an der Expertise von Ginkgo Bioworks und Zymergen orientierte, anpassbare System konzentriert sich darauf, Arbeitsabläufe für anaerobe Organismen zu automatisieren, eine grundlegende Anforderung für die Forschungsprogramme des GLBRC. Die Technologie zielt darauf ab, dem GLBRC zu helfen, seine Mission zu verbessern, eine kostengünstige und nachhaltige Biokraftstoffproduktion in großem Maßstab zu ermöglichen.

Positive
  • Secured contract with DOE-funded research center for automation system deployment
  • System capable of resolving 80-90% of errors remotely through Catalyst Flow service
  • Technology leverages combined expertise from Ginkgo Bioworks and Zymergen acquisitions
Negative
  • None.

Insights

This strategic deployment of Ginkgo's automation technology at GLBRC marks a significant milestone in the company's automation business expansion. The system's sophisticated capabilities - particularly its unique combination of anaerobic-enabled operations and multi-user flexibility - position Ginkgo to capture high-value contracts in the growing $8.8 billion laboratory automation market.

The technology's differentiating features are particularly noteworthy: 1) The ability to handle both aerobic and anaerobic conditions in a single platform, 2) Multi-user support for simultaneous experiments and 3) The Catalyst Flow remote monitoring system with 80-90% error resolution capability. These features address critical pain points in research laboratories, potentially creating a compelling competitive advantage in the automation solutions market.

This partnership has broader implications for Ginkgo's business model:

  • Validates their automation technology in a prestigious research setting
  • Creates a referenceable case study for similar institutional sales
  • Demonstrates capability to customize solutions for complex research environments
  • Establishes foothold in the growing biofuels research sector

The Catalyst Flow remote monitoring system is particularly innovative, as it significantly reduces operational downtime and maintenance costs - key selling points for institutional clients. This could lead to recurring revenue streams through service contracts and system support, expanding beyond mere hardware sales.

This deployment represents a strategic pivot in Ginkgo's business model, expanding beyond their core synthetic biology platform into high-value automation solutions. The choice to target biofuels research is particularly astute given the sector's growth potential amid increasing focus on sustainable energy alternatives.

The technical sophistication of the system - particularly its anaerobic capabilities and multi-user flexibility - demonstrates Ginkgo's deep understanding of research needs in synthetic biology. This expertise, derived from their internal operations and Zymergen acquisition, creates significant barriers to entry for potential competitors.

The broader implications for Ginkgo's business are substantial:

  • Diversifies revenue streams beyond their traditional platform services
  • Leverages existing technical expertise into new market opportunities
  • Creates potential for expansion into other research institutions and commercial laboratories
  • Strengthens their position in the sustainable energy sector

The successful deployment at GLBRC could serve as a blueprint for similar installations at other Department of Energy research centers and academic institutions, potentially creating a significant new revenue stream for Ginkgo. This move aligns with their platform strategy while opening new markets for their automation expertise.

Customizable, anaerobic-enabled system aims to accelerate discovery and development of sustainable biofuels at the University of Wisconsin–Madison's GLBRC

BOSTON, Jan. 23, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Ginkgo Automation will design and deploy a flexible, anaerobic-enabled laboratory automation system for the Great Lakes Bioenergy Research Center (GLBRC), a U.S. Department of Energy-funded Bioenergy Research Center at the University of Wisconsin–Madison. This new system is designed to support the diverse needs of multiple investigators and research teams simultaneously, enabling GLBRC scientists to more efficiently discover and optimize synthesis of biofuels and bioproducts from plant biomass.

GLBRC's mission involves numerous investigators tackling a variety of scientific challenges, requiring flexible and robust research infrastructure. The anaerobic-capable automation system Ginkgo Automation will develop is designed to enable GLBRC scientists to run multiple, diverse experiments at once, across both aerotolerant and anaerobic conditions, while increasing "walkaway" time—allowing investigators to spend more time interpreting data and planning the next generation of experiments rather than tending to routine laboratory tasks. By consolidating diverse experimental needs into a single, flexible system, Ginkgo Automation expects to help GLBRC advance its mission of enabling cost-effective, sustainable biofuel production at scale.

Ginkgo Automation's capabilities are built on years of internal expertise honed at Ginkgo Bioworks and Zymergen, encompassing hardware design, software integration, and applications development. Ginkgo Automation brings significant prior experience in automating workflows for anaerobic organisms, a key requirement for many of GLBRC's research programs. The result is a customizable, future-forward system that can be easily adapted to meet emerging research needs and support more complex workflows as GLBRC continues to pioneer innovations in the bioenergy space.

In addition to providing advanced automation hardware and software, Ginkgo Automation's deployment at GLBRC will include access to Catalyst Flow, a fully remote, active error resolution and troubleshooting support service. Catalyst Flow's proactive monitoring is expected to enable Ginkgo's scientists and engineers to identify and resolve approximately 80-90% of system errors remotely, without the need for user-initiated tickets. Remote recovery is especially critical when working within an anaerobic chamber, because of how disruptive environmental breaches are to research throughput. This helps enable extended walkaway time, improved instrument uptime, and minimized interruptions to research activities, allowing investigators at GLBRC to focus on innovation rather than maintenance.

"This project brings us one step closer to transforming the way researchers leverage laboratory automation," said Will Serber, Head of Ginkgo Automation. "With the design of this new, automated, anaerobic-enabled system, we're not just pushing boundaries—we're reimagining what's possible in the lab. By giving GLBRC investigators the ability to run flexible, multi-user, lab-directed evolution workflows in a highly automated manner, we expect this system to accelerate scientific progress. Ultimately, it's about empowering researchers to achieve more with less effort and drive real-world impact in biofuels and bioproducts development."

"We're excited to incorporate this advanced automation system into our workflows," said Michael Botts, Laboratory Automation Coordinator at GLBRC. "Our researchers tackle a wide range of scientific challenges, from optimizing microbial conversion processes to exploring new feedstocks. Having a single, flexible platform that can manage both anaerobic and aerobic conditions—and can run multiple experiments simultaneously—will be a game-changer. It frees our scientists to focus on innovation and analysis, rather than routine lab tasks, ultimately helping us advance our mission more efficiently."

To learn more about how you can leverage Ginkgo's Automation - built by scientists for scientists - please visit our website.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.

GINKGO BIOWORKS INVESTOR CONTACT:
investors@ginkgobioworks.com

GINKGO BIOWORKS MEDIA CONTACT:
press@ginkgobioworks.com

Forward-Looking Statements of Ginkgo Bioworks

This press release contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding the capabilities and potential success of the partnership and Ginkgo's cell programming platform. These forward-looking statements generally are identified by the words "believe," "can," "project," "potential," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) volatility in the price of Ginkgo's securities due to a variety of factors, including changes in the competitive and highly regulated industries in which Ginkgo operates and plans to operate, variations in performance across competitors, and changes in laws and regulations affecting Ginkgo's business, (ii) the ability to implement business plans, forecasts, and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry, including due to advancements in technology, emerging competition and evolution in industry demands, standards and regulations, (vi) the outcome of any pending or potential legal proceedings against Ginkgo, (vii) our ability to realize the expected benefits from and the success of our Foundry platform programs, (viii) our ability to successfully develop engineered cells, bioprocesses, data packages or other deliverables, and (ix) the product development or commercialization success of our customers. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the "Risk Factors" section of Ginkgo's annual report on Form 10-K filed with the U.S. Securities and Exchange Commission (the "SEC") on February 29, 2024, Ginkgo's most recent quarterly report on Form 10-Q, and other documents filed by Ginkgo from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Ginkgo assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Ginkgo does not give any assurance that it will achieve its expectations.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-automation-to-deploy-flexible-laboratory-automation-system-for-cutting-edge-biofuels-and-bioproducts-research-at-great-lakes-bioenergy-research-center-glbrc-302358623.html

SOURCE Ginkgo Bioworks

FAQ

What is the purpose of Ginkgo Bioworks' (DNA) new automation system for GLBRC?

The system aims to accelerate the discovery and development of sustainable biofuels by enabling scientists to run multiple experiments simultaneously across aerotolerant and anaerobic conditions, while increasing research efficiency.

How will Ginkgo's (DNA) Catalyst Flow service benefit GLBRC researchers?

Catalyst Flow provides remote error resolution and troubleshooting support, expected to resolve 80-90% of system errors remotely without user intervention, minimizing research interruptions.

What unique capabilities does Ginkgo's (DNA) automation system offer for GLBRC?

The system offers flexible, multi-user capabilities, handles both anaerobic and aerobic conditions, and supports diverse experimental needs in a single platform.

How does Ginkgo's (DNA) automation system impact GLBRC's research efficiency?

The system increases 'walkaway' time, allowing researchers to focus more on data interpretation and experiment planning rather than routine laboratory tasks.

Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

DNA Rankings

DNA Latest News

DNA Stock Data

701.24M
54.55M
6.68%
68.36%
12.48%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
BOSTON